For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240416:nRSP8437Ka&default-theme=true
RNS Number : 8437K GSK PLC 16 April 2024
The following amendment has been made to the 'Director/PDMR Shareholding'
announcement released on 15 April 2024 at 15:30 under RNS No 6703K:
- A typographical correction to the share price for the transaction
shown in the table below.
All other details to the original announcement remain unchanged.
The amended table is shown below.
1. Details of PDMR/person closely associated with them ('PCA')
a) Name David Redfern
b) Position/status Chief Strategy Officer
c) Initial notification/ Amendment
amendment
2. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transaction(s) has been conducted
a) Description of the financial instrument Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN: GB00BN7SWP63
b) Nature of the transaction Acquisition of Ordinary Shares following the re-investment of dividends paid
to shareholders on 11 April 2024, on Ordinary Shares held within an ISA
c) Price(s) and volume(s) Price(s) Volume(s)
£16.3860 19
d) Aggregated information N/A (single transaction)
Aggregated volume Price
e) Date of the transaction 2024-04-12
f) Place of the transaction London Stock Exchange (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHXQLFFZZLBBBD